The Irish VC ep39: Building a Rare Disease Pharma Startup in Europe - Oranda Therapeutics

<p>In this episode, Ahmed Alderzi, CEO and co-founder of Oranda Therapeutics, shares insights into building a biotech startup focused on rare diseases, the unique approach of Oranda, and lessons learned from his 30+ years experience. Discover how they navigate the complexities of drug commercialisation and their ambitious plans for Europe and beyond.</p><p>Topics featured throughout the epidode:</p><ul><li>Oranda&#39;s unique platform for late-stage medicines</li><li>The significance of market exclusivity and generics</li><li>Building a biotech startup in Ireland and Europe</li><li>The importance of team and culture in startups</li><li>Navigating regulatory and market access in pharma</li><li>The impact of rare diseases and patient needs</li><li>Funding and investor relations in biotech</li><li>Operational strategies for a virtual team</li></ul><ul><li>&quot;Both industries are needed to serve patients&quot;</li><li>&quot;Eighty percent of medicines in Europe are generics&quot;</li><li>&quot;There are seven thousand named rare diseases&quot;</li></ul>